Pure Global

Revascularization Device - India CDSCO Medical Device Registration

Revascularization Device is a medical device registered with India's Central Drugs Standard Control Organization (CDSCO) under UID IMP/MD/2020/000208_8e7e0dc6a79258796389636d52125b9b_99d951fa60072c75b1415a59e119cc90. This device is marketed under the brand name Embotrap II. The license holder is Johnson & Johnson Private Limited, and it is classified as Device Class Class D. The approving authority is CDSCO.

This page provides comprehensive regulatory information including complete registration details, license holder information, device classification, and related products. Pure Global AI offers free access to 71,807+ India medical device registrations, helping global MedTech companies identify partners, analyze markets, and discover business opportunities efficiently.

Free Database
Powered by Pure Global AI
CDSCO Registered
Class Class D
Revascularization Device
UID: IMP/MD/2020/000208_8e7e0dc6a79258796389636d52125b9b_99d951fa60072c75b1415a59e119cc90

Brand Name

Embotrap II

Device Class

Class D

Approving Authority

CDSCO

Product Information

It is intended to be used to restore blood flow in patients experiencing an acute ischemic stroke due to a large vessel neurovascular occlusion. The device is designed for use in the anterior and posterior neurovasculature in vessels of diameter 1.5mm to 5mm, such as the internal carotid artery, the M1 and M2 segments of the middle cerebral artery, the A1 and A2 segments of the anterior cerebral artery, the basilar, the posterior cerebral and the vertebral arteries. The Device should only be used by physicians trained in neurointerventional catheterization and the treatment of ischemic stroke.

Pure Global
DJ Fang

DJ Fang

MedTech Regulatory Expert

Need help with 30+ markets registration?

Pricing